Private Advisor Group, LLC

Position in ESPR — Esperion Therapeutics, Inc.

CIK 1567755 MORRISTOWN, NJ

Position in ESPR

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$102,323

-$3,457 QoQ

Shares Held

32,381

-16.1% QoQ

Ownership

0.013%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#14

of 35 holders

Holding Since

Jun 2020

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Private Advisor Group, LLC holds $6,097,763 across 11 Drug Manufacturers - Specialty & Generic names. ESPR ranks #8 (1.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HIMS	Hims & Hers Health, Inc.	45,162	$1,565,766
2	ZTS	Zoetis Inc.	14,568	$1,046,856
3	AMRX	Amneal Pharmaceuticals, Inc.	57,998	$1,003,945
4	UTHR	UNITED THERAPEUTICS Corp	1,388	$752,060
5	TEVA	Teva Pharmaceutical Industries Ltd	18,399	$623,358
6	VTRS	Viatris Inc	35,520	$564,057
7	HLN	Haleon plc	29,818	$278,201
8	ESPR	Esperion Therapeutics, Inc. This page	32,381	$102,323

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$102,323	32,381	-16.1%	Shares	Sole	2026-07-27
2026-03-31	$105,780	38,606	0.0%	Shares	Sole	2026-04-27
2025-12-31	$142,842	38,606	-28.0%	Shares	Sole	2026-02-17
2025-09-30	$142,055	53,606	+33.7%	Shares	Sole	2025-11-13
2025-06-30	$39,303	40,106	0.0%	Shares	Sole	2025-08-11
2025-03-31	$57,752	40,106	+33.2%	Shares	Sole	2025-05-05
2024-12-31	$66,233	30,106	-0.5%	Shares	Sole	2025-02-03
2024-09-30	$49,945	30,270	+0.3%	Shares	Sole	2024-10-22
2024-06-30	$66,977	30,170	+4.7%	Shares	Sole	2024-08-05
2024-03-31	$77,259	28,828	0.0%	Shares	Sole	2024-04-30
2023-12-31	$86,195	28,828	+0.8%	Shares	Sole	2024-02-06
2023-09-30	$28,033	28,606	0.0%	Shares	Sole	2023-11-03
2023-06-30	$39,762	28,606	+2342.9%	Shares	Sole	2023-08-10
2020-06-30	$60,084	1,171	—	Shares	Sole	2020-08-17
No filing history on record for this holder in this stock.